Lungs News and Research

RSS

September issue of JACR summarizes methods for radiation dose optimization in chest CT scans

An article in the September issue of the Journal of the American College of Radiology summarizes methods for radiation dose optimization in chest computed tomography (CT) scans.

2 Sep 2011

RI Hospital researcher supports use of ablation procedures for treatment of lung cancer

The journal Radiology will publish in its September issue an article written by Damian E. Dupuy, M.D., director of tumor ablation at Rhode Island Hospital, supporting the use of ablation procedures for the treatment of lung cancer.

2 Sep 2011

FDA approves crizotinib for treatment of ALK-positive lung cancer

In a major triumph for personalized medicine, the FDA approved the drug crizotinib for use with the lung cancer type known as ALK-positive.

2 Sep 2011

Fibrous stroma can help predict aggressiveness of squamous cell carcinoma

The nature of the connective tissue surrounding lung cancer nests can help predict the aggressiveness of squamous cell carcinoma, according to research published in the September issue of the Journal of Thoracic Oncology, the official publication of the International Association for the Study of Lung Cancer.

2 Sep 2011

LCA applauds FDA approval of Xalkori for ALK positive non-small cell lung cancer

Lung Cancer Alliance (LCA) applauds the Food and Drug Administration (FDA) approval of Xalkori (crizotinib) with non-small cell lung cancer (NSCLC) who are ALK positive. The drug was approved based on data from two clinical trials, both of which showed a significant increase in overall survival.

2 Sep 2011

MRSA ‘superbug’: Everyone at risk!

Methicillin-resistant Staphylococcus aureus (MRSA), a type of staph bacteria that does not respond to commonly used antibiotic treatments, is a type of infection that has been a problem in hospital settings for many years. Back in 2000 it began steadily making its way into the lives of otherwise healthy people, especially children, who are not typically at risk for the fast-moving bacteria.

2 Sep 2011

9/11 firefighters at greater risk of cancer

A new study shows that firefighters who were exposed to toxic dust and fumes clogging the air after the World Trade Center towers collapsed 10 years ago are more likely to develop cancer.

2 Sep 2011

New minimally invasive technique now a feasible option to treat scoliosis in teenagers

Minimally invasive surgery to treat scoliosis in teenagers is now a "feasible option," according to Vishal Sarwahi, MD, Director of Spine Deformity Surgery at Montefiore Medical Center.

31 Aug 2011

Creighton pharmacology professor receives AAF's Early Excellence Award

Yaping Tu, Ph.D., associate professor of pharmacology at Creighton University School of Medicine, has received a $450,000 Early Excellence Award from the American Asthma Foundation.

31 Aug 2011

Cell's reserve fighting force shrinks with age: Study

When the body fights oxidative damage, it calls up a reservist enzyme that protects cells - but only if those cells are relatively young, a study has found.

31 Aug 2011

Positive results from Pearl's formoterol fumarate MDI Phase 2b trial on moderate-to-severe COPD

Pearl Therapeutics Inc. today announced positive results from a randomized, double-blind, Phase 2b, dose-ranging study of its formoterol fumarate metered dose inhaler (FF MDI; PT005), a long-acting beta-2 agonist (LABA) compared to placebo and Foradil Aerolizer in patients with moderate-to-severe COPD.

31 Aug 2011

Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

Aeterna Zentaris Inc. today announced that a poster on its novel orally active anticancer Erk inhibitor, which includes AEZS-131, was presented at the 242nd American Chemical Society National Meeting held at the Colorado Convention Center in Denver, Colorado.

30 Aug 2011

DNA sequencing pioneer, two pharmaceutical researchers recognized as ACS 'Heroes of Chemistry'

Two scientists developed a new drug that helped pioneer the era of "personalized medicine" for cancer patients, an approach in which one-size-fits-all drugs yield to medicines customized to the genetic endowment of individual patients. Another scientist invented today's predominant technology for genetic sequencing, deciphering the genetic blueprint in the DNA that makes up the genes of living things.

30 Aug 2011

Educational program about cardiovascular prevention in children can reduce parents' CVD risk

"A multidisciplinary educational programme in cardiovascular prevention directed to children of school age can reduce their parents' cardiovascular risk. Cardiovascular prevention could have more success focusing on children first, inducing healthier lifestyle habits in the whole family, "said investigator Luciana Fornari, from the University of Sao Paulo, Brazil.

30 Aug 2011

High risk of serious complications or death in children with SP-HUS

Hemolytic uremic syndrome (HUS) caused by infection with pneumococcal bacteria leads to severe illness—with a high rate of irreversible kidney damage—in infants and young children, reports a study in the September issue of The Pediatric Infectious Disease Journal.

30 Aug 2011

Study: Social partners can help extend memory

Effective memory is a key ability for independent living in later life, and a new Iowa State University study is among the first to report that social partners can help extend memory.

30 Aug 2011

Roundup: Calif. ruling may extend mental health coverage; Conn. dropping early intervention program; Alaska clinic focuses on Medicare patients

A Northern California woman's treatment for anorexia at a residential facility was medically necessary and must be covered by her healthcare plan, a federal appeals court has ruled in a case that could lead to more extensive benefits for those being treated for mental illnesses.

30 Aug 2011

Pfizer receives FDA approval of XALKORI for ALK-positive NSCLC

Pfizer Inc. has received FDA approval of XALKORI (crizotinib) capsules - the first and only therapy specifically for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive as detected by an FDA-approved test.

29 Aug 2011

Leucine may help people burn fat during periods of food restriction

Research on Mt. Everest climbers is adding to the evidence that an amino acid called leucine - found in foods, dietary supplements, energy bars and other products - may help people burn fat during periods of food restriction, such as climbing at high altitude, while keeping their muscle tissue.

29 Aug 2011

Pfizer's Xalkori receives FDA approval to treat late-stage NSCLC patients with abnormal ALK gene

The U.S. Food and Drug Administration today approved Xalkori (crizotinib) to treat certain patients with late-stage (locally advanced or metastatic), non-small cell lung cancers (NSCLC) who express the abnormal anaplastic lymphoma kinase (ALK) gene.

29 Aug 2011

Lungs News and Research

September issue of JACR summarizes methods for radiation dose optimization in chest CT scans

RI Hospital researcher supports use of ablation procedures for treatment of lung cancer

FDA approves crizotinib for treatment of ALK-positive lung cancer

Fibrous stroma can help predict aggressiveness of squamous cell carcinoma

LCA applauds FDA approval of Xalkori for ALK positive non-small cell lung cancer

MRSA ‘superbug’: Everyone at risk!

9/11 firefighters at greater risk of cancer

New minimally invasive technique now a feasible option to treat scoliosis in teenagers

Creighton pharmacology professor receives AAF's Early Excellence Award

Cell's reserve fighting force shrinks with age: Study

Positive results from Pearl's formoterol fumarate MDI Phase 2b trial on moderate-to-severe COPD

Results of Aeterna Zentaris' AEZS-131 anticancer Erk inhibitor presented at ACS 2011 meeting

DNA sequencing pioneer, two pharmaceutical researchers recognized as ACS 'Heroes of Chemistry'

Educational program about cardiovascular prevention in children can reduce parents' CVD risk

High risk of serious complications or death in children with SP-HUS

Study: Social partners can help extend memory

Roundup: Calif. ruling may extend mental health coverage; Conn. dropping early intervention program; Alaska clinic focuses on Medicare patients

Pfizer receives FDA approval of XALKORI for ALK-positive NSCLC

Leucine may help people burn fat during periods of food restriction

Pfizer's Xalkori receives FDA approval to treat late-stage NSCLC patients with abnormal ALK gene

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Latest News